Receptors

Results: 2044



#Item
241Olfaction / Nervous system / Integral membrane proteins / Protein families / Sensory receptors / Odor / Olfactometer / Olfactory receptor neuron / Drosophila melanogaster / Biology / Olfactory system / Chemistry

3625 The Journal of Experimental Biology 213, © 2010. Published by The Company of Biologists Ltd doi:jebOlfactory modulation of flight in Drosophila is sensitive, selective and rapid

Add to Reading List

Source URL: wilson.med.harvard.edu

Language: English - Date: 2010-10-20 13:33:09
242Toll-like receptors / Toll-like receptor 11 / TLR 1

SummerWeek Undergraduate Resident Semester Hour TLR 1415 Total TLR 1314 Total TLR 1213 Total

Add to Reading List

Source URL: sbs.tamu.edu

Language: English - Date: 2015-04-17 10:42:01
243Neurophysiology / G protein coupled receptors / Neurology / Catecholamines / Dopamine / Cabergoline / Haloperidol / Chemical synapse / Neuron / Biology / Neuroscience / Mind

Behavioral Neuroscience 2006, Vol. 120, No. 3, 497–517 Copyright 2006 by the American Psychological Association/$12.00 DOI:

Add to Reading List

Source URL: psych.colorado.edu

Language: English - Date: 2006-09-05 12:30:12
244Merck KGaA / Pharmacology / Serono / Merck & Co. / Serostim / Kommanditgesellschaft auf Aktien / Interferon beta-1a / Merck Manual of Diagnosis and Therapy / Genset Corporation / Merck / Pharmaceutical industry / Pharmaceutical sciences

News Release June 8, 2011 Affectis Pharmaceuticals and Merck Serono Announce an Agreement to Develop Oral Drugs for Neurodegenerative Diseases Merck Serono to develop compounds from Affectis targeting P2X7 receptors

Add to Reading List

Source URL: www.bayernkapital.de

Language: English - Date: 2011-06-14 06:59:15
245Biochemistry / Laboratory techniques / Molecular biology / Polymerase chain reaction / Vascular endothelial growth factor / Angiogenesis inhibitor / VEGF receptors / Angiogenesis / Real-time polymerase chain reaction / Biology / Angiology / Medicine

This article appeared in a journal published by Elsevier. The attached copy is furnished to the author for internal non-commercial research and education use, including for instruction at the authors institution and shar

Add to Reading List

Source URL: en.actc-lab.chem.uoa.gr

Language: English - Date: 2012-03-25 13:29:56
246Neurochemistry / Dopamine receptor D2 / Dopamine receptor / Dysbindin / Dopamine / Istituto Italiano di Tecnologia / Agonist / Biology / G protein coupled receptors / Medicine

TITLE New therapeutic indication of the agonist and antagonist of D2 dopamine receptors INVENTORS Francesco Papaleo, Diego Scheggia

Add to Reading List

Source URL: www.iit.it

Language: English - Date: 2015-02-04 04:04:07
247Cytokines / Stromal cell-derived factor-1 / Cancer research / CXC chemokine receptors / Insulin / Nanoparticle / Cell therapy / Biology / Cell biology / Nanotechnology

analysis from the makers of and

Add to Reading List

Source URL: bindtherapeutics.com

Language: English - Date: 2014-01-26 13:16:07
248Olfaction / Nervous system / Sensory receptors / G protein coupled receptors / Protein families / Odor / Olfactory receptor neuron / Olfactory receptor / Antennal lobe / Biology / Chemistry / Olfactory system

J Neurophysiol 108: 2051–2059, 2012. First published July 18, 2012; doi:jnTransduction in Drosophila olfactory receptor neurons is invariant to air speed Yi Zhou and Rachel I. Wilson

Add to Reading List

Source URL: wilson.med.harvard.edu

Language: English - Date: 2012-10-08 07:49:55
249Tyrosine kinase receptors / Pharmacology / Ribbon symbolism / Monoclonal antibodies / Immunology / HER2/neu / Trastuzumab / Targeted therapy / Pertuzumab / Medicine / Bristol-Myers Squibb / Biology

Bristol-Myers Squibb Enters into Agreement that Provides an Exclusive Option to Acquire F-star Alpha Ltd. and its Novel HER2-Targeted Therapy (NEW YORK and CAMBRIDGE, UK – October 28, Bristol-Myers Squibb Compa

Add to Reading List

Source URL: www.f-star.com

Language: English - Date: 2014-10-28 07:38:04
250Immune system / Immunology / Autoimmune diseases / Monoclonal antibodies / Glycoproteins / Inflammatory bowel disease / Biologic / Tumor necrosis factor-alpha / Antibody / Medicine / Biology / Anatomy

Avaxia Biologics is Awarded U.S. Patent for Antibody Therapy for Modulating Function of Intestinal Receptors and Methods of Treating Diabetes and Obesity LEXINGTON, Mass. – September 18, 2012 – Avaxia Biologics, Inc.

Add to Reading List

Source URL: www.avaxiabiologics.com

Language: English - Date: 2014-02-06 00:38:27
UPDATE